The Promising Role of Autologous and Allogeneic Mesenchymal Stromal Cells in Managing Knee Osteoarthritis. What is Beyond Mesenchymal Stromal Cells?

Overview

Journal J Clin Orthop Trauma

Specialty Orthopedics

Date 2022 Mar 4

PMID 35242531

Authors

Vivek Pandey

Sandesh Madi

Pawan Gupta

Affiliations

Soon will be listed here.

Abstract

Mesenchymal stromal cells (MSCs) express a wide range of properties anticipated to be beneficial for treating genetic, mechanical, and age-related degeneration in diseases such as osteoarthritis (OA). Although contemporary conservative management of OA is successful in many patients with mild-moderate OA, it often fails to improve symptoms in many patients who are not a candidate for any surgical management. Further, existing conservative treatment strategies do not prevent the progression of the disease and therefore fail to provide a long-term pain-free life. On the other hand, tremendous progress has been taking place in the exciting field of regenerative medicine involving MSCs (autologous and allogeneic), with promising translation taking place from basic science to the bedside. In this review, we comprehensively discuss the potential role of MSCs in treating OA, both autologous and off-the-shelf, allogeneic stem cells. Further, newer therapies are in the offing to treat OA, such as exosomes and growth factors.

Citing Articles

Dual-Double Stem Cell Ovarian Therapy: A Comprehensive Approach in Regenerative Medicine.

Ljubic A, Dinic M, Svraka D, Vujovic S Int J Mol Sci. 2025; 26(1.

PMID: 39795929 PMC: 11719681. DOI: 10.3390/ijms26010069.

Pathologically altered articular cartilage attracts intense chondrocyte invasion into the extracellular matrix: in vitro pilot study.

Shestakova V, Klabukov I, Kolobaev I, Rao L, Atiakshin D, Ignatyuk M Knee Surg Relat Res. 2024; 36(1):42.

PMID: 39627845 PMC: 11613889. DOI: 10.1186/s43019-024-00249-y.

Role of nano-hydrogels coated exosomes in bone tissue repair.

Pan Y, Li Y, Dong W, Jiang B, Yu Y, Chen Y Front Bioeng Biotechnol. 2023; 11:1167012.

PMID: 37229488 PMC: 10204869. DOI: 10.3389/fbioe.2023.1167012.

Osteoarthritis as an Umbrella Term for Different Subsets of Humans Undergoing Joint Degeneration: The Need to Address the Differences to Develop Effective Conservative Treatments and Prevention Strategies.

Hart D Int J Mol Sci. 2022; 23(23).

PMID: 36499704 PMC: 9736942. DOI: 10.3390/ijms232315365.

Peripheral Blood-Derived Stem Cells for the Treatment of Cartilage Injuries: A Systematic Review.

Zhu Y, Fu W Front Bioeng Biotechnol. 2022; 10:956614.

PMID: 35935493 PMC: 9355401. DOI: 10.3389/fbioe.2022.956614.

References

Mamidi M, Ganesan Nathan K, Singh G, Thrichelvam S, Mohd Yusof N, Fakharuzi N . Comparative cellular and molecular analyses of pooled bone marrow multipotent mesenchymal stromal cells during continuous passaging and after successive cryopreservation. J Cell Biochem. 2012; 113(10):3153-64. DOI: 10.1002/jcb.24193. View

Lai R, Arslan F, Lee M, Sze N, Choo A, Chen T . Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury. Stem Cell Res. 2010; 4(3):214-22. DOI: 10.1016/j.scr.2009.12.003. View

Zhao J, Huang H, Liang G, Zeng L, Yang W, Liu J . Effects and safety of the combination of platelet-rich plasma (PRP) and hyaluronic acid (HA) in the treatment of knee osteoarthritis: a systematic review and meta-analysis. BMC Musculoskelet Disord. 2020; 21(1):224. PMC: 7149899. DOI: 10.1186/s12891-020-03262-w. View

Turinetto V, Vitale E, Giachino C . Senescence in Human Mesenchymal Stem Cells: Functional Changes and Implications in Stem Cell-Based Therapy. Int J Mol Sci. 2016; 17(7). PMC: 4964536. DOI: 10.3390/ijms17071164. View

He L, He T, Xing J, Zhou Q, Fan L, Liu C . Bone marrow mesenchymal stem cell-derived exosomes protect cartilage damage and relieve knee osteoarthritis pain in a rat model of osteoarthritis. Stem Cell Res Ther. 2020; 11(1):276. PMC: 7350730. DOI: 10.1186/s13287-020-01781-w. View

Freitag J, Bates D, Wickham J, Shah K, Huguenin L, Tenen A . Adipose-derived mesenchymal stem cell therapy in the treatment of knee osteoarthritis: a randomized controlled trial. Regen Med. 2019; 14(3):213-230. DOI: 10.2217/rme-2018-0161. View

Wakitani S, Okabe T, Horibe S, Mitsuoka T, Saito M, Koyama T . Safety of autologous bone marrow-derived mesenchymal stem cell transplantation for cartilage repair in 41 patients with 45 joints followed for up to 11 years and 5 months. J Tissue Eng Regen Med. 2010; 5(2):146-50. DOI: 10.1002/term.299. View

Mathieu M, Martin-Jaular L, Lavieu G, Thery C . Specificities of secretion and uptake of exosomes and other extracellular vesicles for cell-to-cell communication. Nat Cell Biol. 2019; 21(1):9-17. DOI: 10.1038/s41556-018-0250-9. View

Vinatier C, Bouffi C, Merceron C, Gordeladze J, Brondello J, Jorgensen C . Cartilage tissue engineering: towards a biomaterial-assisted mesenchymal stem cell therapy. Curr Stem Cell Res Ther. 2009; 4(4):318-29. PMC: 3218613. DOI: 10.2174/157488809789649205. View

10.

Martel-Pelletier J, Barr A, Cicuttini F, Conaghan P, Cooper C, Goldring M . Osteoarthritis. Nat Rev Dis Primers. 2016; 2:16072. DOI: 10.1038/nrdp.2016.72. View

11.

Jungbluth P, Grassmann J, Thelen S, Wild M, Sager M, Windolf J . Concentration of platelets and growth factors in platelet-rich plasma from Goettingen minipigs. GMS Interdiscip Plast Reconstr Surg DGPW. 2015; 3:Doc11. PMC: 4582514. DOI: 10.3205/iprs000052. View

12.

Koh Y, Kwon O, Kim Y, Choi Y, Tak D . Adipose-Derived Mesenchymal Stem Cells With Microfracture Versus Microfracture Alone: 2-Year Follow-up of a Prospective Randomized Trial. Arthroscopy. 2015; 32(1):97-109. DOI: 10.1016/j.arthro.2015.09.010. View

13.

Hatzistergos K, Blum A, Ince T, Grichnik J, Hare J . What is the oncologic risk of stem cell treatment for heart disease?. Circ Res. 2011; 108(11):1300-3. PMC: 3390911. DOI: 10.1161/CIRCRESAHA.111.246611. View

14.

Shapiro S, Kazmerchak S, Heckman M, Zubair A, OConnor M . A Prospective, Single-Blind, Placebo-Controlled Trial of Bone Marrow Aspirate Concentrate for Knee Osteoarthritis. Am J Sports Med. 2016; 45(1):82-90. DOI: 10.1177/0363546516662455. View

15.

Phinney D, Kopen G, Righter W, Webster S, Tremain N, Prockop D . Donor variation in the growth properties and osteogenic potential of human marrow stromal cells. J Cell Biochem. 1999; 75(3):424-36. View

16.

Pal C, Singh P, Chaturvedi S, Pruthi K, Vij A . Epidemiology of knee osteoarthritis in India and related factors. Indian J Orthop. 2016; 50(5):518-522. PMC: 5017174. DOI: 10.4103/0019-5413.189608. View

17.

Le Blanc K, Ringden O . Immunomodulation by mesenchymal stem cells and clinical experience. J Intern Med. 2007; 262(5):509-25. DOI: 10.1111/j.1365-2796.2007.01844.x. View

18.

Caplan A . New MSC: MSCs as pericytes are Sentinels and gatekeepers. J Orthop Res. 2017; 35(6):1151-1159. DOI: 10.1002/jor.23560. View

19.

Chullikana A, Majumdar A, Gottipamula S, Krishnamurthy S, Kumar A, Prakash V . Randomized, double-blind, phase I/II study of intravenous allogeneic mesenchymal stromal cells in acute myocardial infarction. Cytotherapy. 2014; 17(3):250-61. DOI: 10.1016/j.jcyt.2014.10.009. View

20.

Kuah D, Sivell S, Longworth T, JAMES K, Guermazi A, Cicuttini F . Safety, tolerability and efficacy of intra-articular Progenza in knee osteoarthritis: a randomized double-blind placebo-controlled single ascending dose study. J Transl Med. 2018; 16(1):49. PMC: 5840781. DOI: 10.1186/s12967-018-1420-z. View